Pricing Log in Create free account

Alterity Therapeutics Limited - Sponsored ADR (ATHE) vs Actinium Pharmaceuticals, Inc. (ATNM)

Alterity Therapeutics Limited - Sponsored ADR and Actinium Pharmaceuticals, Inc. are both Biotechnology companies. Alterity Therapeutics Limited - Sponsored ADR and Actinium Pharmaceuticals, Inc. are of similar size ($42.4M and $40.9M). Alterity Therapeutics Limited - Sponsored ADR has negative trailing earnings, so its P/E is not meaningful; Actinium Pharmaceuticals, Inc. trades at 3.9×. Actinium Pharmaceuticals, Inc. has the higher net margin (32.2% vs 0.00%) and the higher return on invested capital (0.00% vs 0.00%). Across the 11 metrics below, Actinium Pharmaceuticals, Inc. leads on 7 and Alterity Therapeutics Limited - Sponsored ADR on 4.

Valuation

Metric ATHE ATNM Biotechnology median
P/E n/m 3.94 10.60
P/S — 1.27 9.40
P/B n/m 1.47 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.94 0.78 0.66
EV/Sales n/m 0.23 9.02
Earnings yield 0.00% 25.35% (32.88%)
Free cash flow yield 0.00% (52.14%) (23.13%)

Profitability

Metric ATHE ATNM Biotechnology median
Gross margin 0.00% 98.71% 68.51%
Operating margin — 27.20% 0.00%
Net margin 0.00% 32.18% 0.00%
Free cash flow margin 0.00% (66.16%) 0.00%
Return on equity 0.00% 45.86% (51.96%)
Return on assets 0.00% 21.92% (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ATHE ATNM Biotechnology median
Revenue growth (TTM) — 2,731.18% 6.76%
EPS growth (last fiscal year) (22.97%) 14.17% 29.88%
Revenue growth, 5-year CAGR (1.15%) — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ATHE ATNM Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 14.52 4.08 4.97
Net debt to EBITDA 1.32 1.35 1.01

Dividend

Metric ATHE ATNM Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ATHE ATNM Biotechnology median
Market cap 42.40m 40.87m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack